Skip to content

PHARMACIE LIPSZYC

Active Private limited companyfounded 1994active for 32 yearsRue de l'Aérodrome 4, 4140 SprimontKBO/BCE: BE 0451.958.137

Lifetime

20 annual accounts with figures on one time axis, 32 filings since 1994
peak of €439,949 in 2025
€439,949▲ 11.8%
lowest -€30,078 in 2006
€131,418▲ 30.7%
peak of €359,582 in 2025
€359,582▲ 16.7%
€577,954▲ 17.2%
peak of 4 FTE in 2024
3.9 FTE▼ 2.5%
Board2 names since 2016
1 director
Owners
50%
Documentsfilings and deeds
26-08-202626 days late
2025abbreviated format
Result from €100,565 to €131,418Equity from €308,164 to €359,582Debts from €493,303 to €577,954Cash from €31,803 to €14,956

Key points

from the 2025 annual accounts

Equity

€359,582 ▲ 16.7%

PHARMACIE LIPSZYC has made a profit without a break since 2007.

Staff

5 employees on 31-12-2025
662021442022652023542024342025

In 2025, 3 employees joined and 4 left.

Filings

32 annual accounts since 1994
AprilJune31 JulyOctober200020102020

Ten of the last ten came late. The 2019 accounts came in latest, 69 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as PHARMACIE LIPSZYC has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for PHARMACIE LIPSZYC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director,
  • 50%score equity €500,737 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

1 director appointed · and act as permanent representatives · General meeting of 10-08-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0451958137
Capital conversion General meeting of 17-06-2024 · Gazette deed
reappointed as director acts as permanent representative · “La promotion, l’organisation, la réalisation, la production, l’achat, la vente, la mise en valeur, l’import…” (deed in French) · General meeting of 07-09-2023 · Gazette deed
All 45 events

Comparable companies

same main activity, similar in size and age
Company
PHARMACIE LIPSZYC Sprimont €0.9m €439,949 38.4% 3.9
MELON-WISLEZ Waimes €0.9m €355,237 73.5% 4
CEGEPHAR Fléron €0.8m €487,011 25.5% 4.4
PHARMACIE HITTELET Etalle €1.0m €401,959 26.2% 4
APOTHEEK VAN BESIEN Nieuwpoort €0.9m €380,090 63.1% 3.8
PHARMACIE DE LA SALM Vielsalm €0.8m €449,619 58.2% 4.2
PAVOBUR Vosselaar €0.9m €517,156 37.7% 3.4

These companies have the same main activity as PHARMACIE LIPSZYC: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €778,000 and €1m, founded between 1990 and 1996.

Official details

Source: KBO
Status
Active since 13-01-1994Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.086.084.4734140 Sprimont, since 25-03-1998
Financial year end
31 December
Peppol
Reachable since 12-11-2025
Company details

Annual accounts 2025

≈ €1.5mestimated
€937,536▲ 17.0%
Employeeson 31-12-2025
5▼ 16.7%
Filing
Filed on 26-08-2026
Financials

Insights on PHARMACIE LIPSZYC

PHARMACIE LIPSZYC files the abbreviated format. That format states no turnover. The gross margin rose from €106,444 in 2006 to €439,949 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMACIE LIPSZYC

What is the company number of PHARMACIE LIPSZYC?
The company number of PHARMACIE LIPSZYC is 0451.958.137. The VAT number is the same number with BE in front: BE 0451.958.137.
Where is PHARMACIE LIPSZYC based?
The registered office is at Rue de l'Aérodrome 4, 4140 Sprimont.Company details
What does PHARMACIE LIPSZYC do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE LIPSZYC?
PHARMACIE LIPSZYC is a private limited company (BV).
When was PHARMACIE LIPSZYC founded?
PHARMACIE LIPSZYC was founded on 13-01-1994.
Is PHARMACIE LIPSZYC still active?
Yes, PHARMACIE LIPSZYC is an active enterprise in the KBO register.
How many employees does PHARMACIE LIPSZYC have?
PHARMACIE LIPSZYC had an average of 3.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE LIPSZYC fall under?
In its 2025 annual accounts, PHARMACIE LIPSZYC states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMACIE LIPSZYC?
The turnover in financial year 2025 is about €1.5m. This figure is estimated from the gross margin of €439,949 and 42 comparable companies (NACE 477). It probably lies between €1.2m and €2.1m.
Is PHARMACIE LIPSZYC profitable?
In financial year 2025, PHARMACIE LIPSZYC made a profit of €131,418.
Where can I find the annual accounts of PHARMACIE LIPSZYC?
PHARMACIE LIPSZYC filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE LIPSZYC due?
PHARMACIE LIPSZYC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.